Clinical Trial Update: A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating long-term maintenance treatment with once-daily Crisaborole 2% ointment in pediatric and adult patients with mild-to-moderate atopic de…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Crisaborole 2% ointment (crisaborole)

Snippet

Sponsor: Pfizer | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2023-03-08